Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on Monday morning,Benzinga reports. HC Wainwright currently has a $30.00 price target on the stock. Several other brokerages have also recently commented on VYGR. Citigroup started coverage on Voyager Therapeutics in a report on Monday, December […]
